Drug resistance of strains of Mycobacterium tuberculosis isolated in Brazil

Microbes and Infection

Volumn 3, Issue 13, 2001, Pages 1111-1113

  Almeida Da Silva, Pedro E ^a   Osório, Marta ^b   Reinhardt, Marcelo C ^c   De Souza Fonseca, Leila ^d   Dellagostin, Odir A ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b Laboratorio Central RS   (Brazil)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Multidrug resistance; Mycobacterium tuberculosis; Treatment

Indexed keywords

BIOLOGICAL MARKER; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; STRAIN DIFFERENCE; TUBERCULOSIS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0034765899     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01471-X     Document Type: Article

References (13)

1. Procurement of second-line antituberculosis drugs for DOTS-PLUS pilot projects
2. Health sector reform in Brazil: Impact on tuberculosis control
3. Mycobacterium tuberculosis: Drug-resistance mechanisms
4. Approaches to tuberculosis drug development
5. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin
6. The impact of drug resistance on the global tuberculosis epidemic
7. Antimycobacterial agents and susceptibility tests
8. RFLP patterns and risk factors for recent tuberculosis transmission among hospitalized tuberculosis patients in Rio de Janeiro, Brazil
9. Genetics of drug resistance in Mycobacterium tuberculosis
10. Molecular determinants of drug resistance in tuberculosis